Skip to content

Clinical trials

Withdrawn Mesothelioma, Malignant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma, Malignant Status: Withdrawn Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20111
20141
20151
20161
20191
20203
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)3
Case Comprehensive Cancer Center1
Health Pharma Professional Research1
Incyte Corporation1
Memorial Sloan Kettering Cancer Center1
Ohio State University Comprehensive Cancer Center1
ProgenaBiome1
Raphael Bueno, MD1
Translational Research in Oncology1
University College, London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma, Malignant14
Carcinoma, Non-Small-Cell Lung4
Mesothelioma4
Small Cell Lung Carcinoma3
Anus Neoplasms1
Carcinoma1
Colorectal Neoplasms1
Lung Neoplasms1
Neoplasm Metastasis1
Neoplasms1

Trials

Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.